Literature DB >> 3765113

Bovine theileriosis in Burundi: chemotherapy with halofuginone lactate.

H H Kiltz, R Humke.   

Abstract

In a field trial 100 cattle suffering from naturally acquired East Coast fever caused by Theileria parva were treated with halofuginone lactate at a dose of 0.6 to 2.0 mg/kg body weight. Records were kept of exact diagnosis, treatment and follow up observations. The total recovery rate was 87%. The rate was highest in local breeds (up to 100%) and lowest in Friesian cattle (61.5%). Two treatments were administered to nine animals, two of which had relapsed four to six days after the first treatment. Halofuginone was well tolerated when the therapeutic dose was diluted in at least 500 ml of water. It proved to be a reliable and effective drug in the treatment of theileriosis under field conditions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3765113     DOI: 10.1007/bf02359523

Source DB:  PubMed          Journal:  Trop Anim Health Prod        ISSN: 0049-4747            Impact factor:   1.559


  3 in total

1.  Chemotherapy of bovine theileriosis with Halofuginone. Short communication.

Authors:  E Schein; W P Voigt
Journal:  Acta Trop       Date:  1979-12       Impact factor: 3.112

2.  [Chemotherapy of cattle theileriosis with halofuginone, an anticoccidian].

Authors:  G Uilenberg; F Jongejan; N M Perie; F F Franssen
Journal:  Rev Elev Med Vet Pays Trop       Date:  1980

3.  Comparison of the antitheilerial effect of Wellcome 993C and halofuginone.

Authors:  D W Morgan; N McHardy
Journal:  Res Vet Sci       Date:  1982-01       Impact factor: 2.534

  3 in total
  1 in total

1.  Prevalence of tick-transmitted pathogens in cattle reveals that Theileria parva, Babesia bigemina and Anaplasma marginale are endemic in Burundi.

Authors:  Lionel Nyabongo; Esther G Kanduma; Richard P Bishop; Eunice Machuka; Alice Njeri; Alain V Bimenyimana; Canesius Nkundwanayo; David O Odongo; Roger Pelle
Journal:  Parasit Vectors       Date:  2021-01-05       Impact factor: 3.876

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.